Bone Protection

Welcome to the Bone Protection Resource Center! Our goal is to provide current information, news, literature, and other resources in this important area of oncology for you and your patients. If you have any feedback or questions, please contact editor@advancedpractitioner.com

David Johnson, PA-C
Director,
Advanced Practice Professional Services
Moffitt Cancer Center

Bone Protection Resource Center

Interview With Nora Watson, PA-C: Establishing a Metastatic Bone Disease Clinic

The Advanced Practitioner's Role in Managing Bone Health in Patients With Cancer

American Cancer Society: Bone Metastases

Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma

Chemocare: Bone Pain

Clinical Trials for Patients With Bone Metastases

Cancer Epidemiology

Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer − Hospital based cohort study

BMJ Open

Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

Oncology Letters

Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer

The Oncologist

Bone metastases detection in patients with breast cancer: Does bone scintigraphy add information to PET/CT?

Cancers

Initiation of antiresorptive drug treatment during endocrine therapy for breast cancer—A retrospective cohort study of 161,492 patients in Germany

Journal of Bone and Mineral Metabolism

Differences between zoledronic acid and denosumab for breast cancer treatment

Frontiers in Oncology

Management of pain in patients with bone metastases

Radiation Oncology

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors

Journal of Bone Oncology

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis

European Journal of Cancer

Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study

Postmenopausal Patient With ER+ Early-Stage Breast Cancer: Bone Protection and Shared Decision-Making

Bone Protection During Chemotherapy in Metastatic Lung Cancer

Dosing and Duration of BMAs in an Older Patient With Prostate Cancer

Take our brief survey to share how your practice manages bone health

Fast Facts #3: Prostate Cancer and Bone Metastases